LOS ANGELES, CA–(Marketwired – Sep 29, 2017) – Subchondral Solutions, Inc. — a medical device company– has just received 510(k) clearance from the Food and Drug Administration (FDA) for its S4 Screw System™. The S4 Screw System™ is a fenestrated cannulated family of screws specifically designed for osteochondral fractures of the joint. “The S4 Screw …
Subchondral Solutions, Inc. Receives 510(k) Clearance From FDA Read More »
Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System™ to treat osteochondral fractures. S4 is the company’s first FDA-cleared device in its platform that will address joint pain and damage with biomechanical and bioactive implants. The approach focuses on early biomechanical support for the entire bone/cartilage unit. Subchondral Solutions was …
Subchondral Solutions Receives FDA Clearance for Fenestrated Cannulated Screws Read More »
Minimally invasive joint reconstruction product line addresses fundamental issue of joint damage HUNTINGTON BEACH, Calif., (July 24, 2020) — Subchondral Solutions, Inc., a medical device company based in Huntington Beach, Calif., has received 510(k) Food and Drug Administration (FDA) clearance for its S-Core™ core-preserving Osteochondral Reconstruction System. S-Core™ is the first and only hydroxyapatite-coated (HA), …
Subchondral Solutions Inc. has received 510(k) clearance from the FDA for its S-core osteochondral reconstruction and joint repair platform technology, according to a company press release. The S-core platform is a hydroxyapatite-coated, bone-preserving, fenestrated and cannulated family of screws, according to the release. It is specifically designed for fixation of osteochondral fractures and other small …
